Does modafinil enhance activity of patients with myotonic dystrophy?
Authors:
Open Access
- 1 January 2007
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neurology
- Vol. 254 (1) , 26-28
Abstract
We performed a double-blind placebo-controlled crossover study in 13 patients with myotonic dystrophy to address the question whether modafinil, known to improve hypersomnolence in myotonic dystrophy, may improve levels of activity as well. We used the Epworth Sleepiness Scale as a measure of hypersomnolence and a structured interview of the patient and the partner or housemate as a measure of activity. We additionally used a restricted form of the RAND-36 to relate a possible improvement of activity to perceived general health. We confirmed earlier positive findings of modafinil regarding reduced somnolence (p = 0.015), but no significant effects were seen regarding activity levels (p = 0.2 for patients’ self-reports and 0.5 for partners’ reports).Keywords
This publication has 6 references indexed in Scilit:
- Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophyNeuromuscular Disorders, 2003
- The relation between daytime sleepiness, fatigue, and reduced motivation in patients with adult onset myotonic dystrophyJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophyNeurology, 2002
- Modafinil for excessive daytime sleepiness in myotonic dystrophyNeurology, 2001
- The rand 36‐item health survey 1.0Health Economics, 1993
- A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleSLEEP, 1991